Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DBIA Probe Info |
![]() |
C69(9.89) | LDD0209 | [1] |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Brentuximab Vedotin | Monoclonal antibody | D03TIS |
Phase 2
Phase 1
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
H22xki-4 | Antibody | D0LE2E | |||
Vt-362 | . | D02SJG | |||
Xmab 2513 | . | DB06324 |
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Ber-h2/Saporin | Antibody | D0A9QL |
References